NO20000107D0 - New mixture - Google Patents

New mixture

Info

Publication number
NO20000107D0
NO20000107D0 NO20000107A NO20000107A NO20000107D0 NO 20000107 D0 NO20000107 D0 NO 20000107D0 NO 20000107 A NO20000107 A NO 20000107A NO 20000107 A NO20000107 A NO 20000107A NO 20000107 D0 NO20000107 D0 NO 20000107D0
Authority
NO
Norway
Prior art keywords
new mixture
mixture
new
Prior art date
Application number
NO20000107A
Other languages
Norwegian (no)
Other versions
NO20000107L (en
Inventor
Paul John Cummings
Ian Frederic Tulloch
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20000107L publication Critical patent/NO20000107L/en
Publication of NO20000107D0 publication Critical patent/NO20000107D0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
NO20000107A 1997-07-11 2000-01-10 New mixture NO20000107D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714675.7A GB9714675D0 (en) 1997-07-11 1997-07-11 Novel composition
PCT/EP1998/004971 WO1999002142A2 (en) 1997-07-11 1998-07-07 Novel composition comprising an ssri and a beta-blocker

Publications (2)

Publication Number Publication Date
NO20000107L NO20000107L (en) 2000-01-10
NO20000107D0 true NO20000107D0 (en) 2000-01-10

Family

ID=10815744

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000107A NO20000107D0 (en) 1997-07-11 2000-01-10 New mixture

Country Status (26)

Country Link
EP (1) EP0996466A2 (en)
JP (1) JP2002508003A (en)
KR (1) KR20010021644A (en)
CN (1) CN1262627A (en)
AP (1) AP2000001728A0 (en)
AR (1) AR016128A1 (en)
AU (1) AU9340198A (en)
BG (1) BG104119A (en)
BR (1) BR9810996A (en)
CA (1) CA2295822A1 (en)
CO (1) CO4950552A1 (en)
DZ (1) DZ2556A1 (en)
EA (1) EA200000112A1 (en)
GB (1) GB9714675D0 (en)
HU (1) HUP0003074A3 (en)
ID (1) ID24191A (en)
IL (1) IL133869A0 (en)
MA (1) MA24604A1 (en)
NO (1) NO20000107D0 (en)
OA (1) OA11276A (en)
PE (1) PE99699A1 (en)
PL (1) PL338017A1 (en)
SK (1) SK72000A3 (en)
TR (1) TR200000074T2 (en)
WO (1) WO1999002142A2 (en)
ZA (1) ZA986138B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69942009D1 (en) 1998-10-15 2010-03-25 Imp Innovations Ltd CONNECTIONS FOR THE TREATMENT OF WEIGHT LOSS
CZ303495B6 (en) 1998-11-02 2012-10-24 Elan Pharma International Limited Multiparticulate modified release composition, use thereof and solid oral dosage form
HU230828B1 (en) 1999-10-29 2018-08-28 Euro Celtique Sa Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
GB0004003D0 (en) * 2000-02-22 2000-04-12 Knoll Ag Therapeutic agents
HU230875B1 (en) 2000-10-30 2018-11-29 Euro-Celtique S.A. Controlled release hydrocodone compositions
WO2006030306A2 (en) * 2004-09-17 2006-03-23 Neurocure Ltd Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder
CN100469356C (en) * 2006-09-08 2009-03-18 山东益康药业有限公司 Slowly released tablet of compound atenolol, and preparation method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732335C2 (en) * 1976-07-27 1983-01-20 Sandoz-Patent-GmbH, 7850 Lörrach Tablet for the enteral administration of indolyloxyalkanolamine derivatives
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug response by a serotonin 1A receptor antagonist
DE69607904T2 (en) * 1995-08-16 2000-10-05 Lilly Co Eli Potentiation of serotonin drug response
EP0792649A1 (en) * 1996-02-29 1997-09-03 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
JP2002508003A (en) 2002-03-12
AU9340198A (en) 1999-02-08
NO20000107L (en) 2000-01-10
GB9714675D0 (en) 1997-09-17
PE99699A1 (en) 1999-12-21
AR016128A1 (en) 2001-06-20
TR200000074T2 (en) 2000-05-22
CO4950552A1 (en) 2000-09-01
IL133869A0 (en) 2001-04-30
KR20010021644A (en) 2001-03-15
CA2295822A1 (en) 1999-01-21
HUP0003074A2 (en) 2001-01-29
BG104119A (en) 2000-12-29
ZA986138B (en) 2000-01-10
DZ2556A1 (en) 2003-02-15
MA24604A1 (en) 1999-04-01
OA11276A (en) 2003-07-31
EP0996466A2 (en) 2000-05-03
CN1262627A (en) 2000-08-09
SK72000A3 (en) 2000-12-11
BR9810996A (en) 2000-08-08
HUP0003074A3 (en) 2001-12-28
ID24191A (en) 2000-07-13
PL338017A1 (en) 2000-09-25
WO1999002142A2 (en) 1999-01-21
WO1999002142A3 (en) 1999-04-15
AP2000001728A0 (en) 2000-03-31
EA200000112A1 (en) 2000-10-30

Similar Documents

Publication Publication Date Title
NO961588D0 (en) New mixture
NO951704D0 (en) Water-repellent mixture
NO993785D0 (en) Mixture where the electrostatic effect fades
NO994003L (en) Pharmaceutical mixture
DK0900021T3 (en) Fungicide mixture
NO20001830D0 (en) New combination
NO20001014L (en) Dermatological mixture
DE69817830D1 (en) SILVERIC SULFUR-VOLCANIZABLE RUBBER MIXTURE
ATE446389T1 (en) ENZYME MIXTURE
NO982732D0 (en) New procedure
NO992427D0 (en) Pharmaceutical surface mixture
NO985864D0 (en) Antiviral mixture
NO20004491D0 (en) Mixture
NO993298D0 (en) New procedure
DK0797386T3 (en) Fungicide mixture
DK0986304T3 (en) Fungicide mixture
NO995796L (en) New procedure
NO20000107D0 (en) New mixture
DK1139758T3 (en) Fungicide mixture
DK0983266T3 (en) New tetrahydrosioquinolinthiophenecarboximidamides
FI974212A (en) Insulator
NO20003834L (en) Mixture
ATE227077T1 (en) FUNGICIDE MIXTURE
FI98053B (en) Mixture
NO972771D0 (en) New receptor

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application